Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice
Open Access
- 4 June 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (6) , e0232800
Abstract
Second primary breast cancer (SPBC) is becoming one of the major obstacles to breast cancer (BC) control. This study was aimed to determine the trend of SPBC incidence over time and the risk of developing SPBC in site-specific primary cancer survivors in the United States. The Surveillance, Epidemiology, and End Results (SEER) 13 registry (1992–2015) was used to identify SPBC patients with previous malignancies. Standardized incidence ratio (SIR) was computed to compare the incidence rates of the observed cases of SPBC in cancer survivors over the expected cases in the general population. Elevated risk of SPBC was observed in women with previous BC (SIR = 1.74) or thyroid cancer (SIR = 1.17). Women with initial skin melanoma in older age (≥50 years) (SIR = 1.11), or White race (SIR = 1.11) presented an elevated incidence of SPBC than the general female population. Besides, Asian/Pacific Islander (API) women with cancer of corpus uteri, ovary, bladder, or kidney were prone to developing SPBC when compared with the general population, with SIRs of 1.61, 1.35, 1.48, and 1.70, respectively. Male BC patients showed profound risk of developing SPBC (SIR = 34.86). Male leukemia patients also presented elevated risk of developing SPBC (SIR = 2.06). Our study suggests significant increase of SPBC in both sexes in the United States. Elevated risk of SPBC exists in survivors with primary BC, female thyroid cancer, male leukemia, and API female cancer patients with primary genitourinary cancer. Our study is helpful in developing strategies for BC control and prevention on specific first primary cancer survivors with an elevated risk of SPBC.Keywords
This publication has 39 references indexed in Scilit:
- BRCA1 and BRCA2 Mutations in the Ovarian Cancer Population across Race and Ethnicity: Special Reference to AsiaOncology, 2013
- Risk of second primary malignancies following cutaneous melanoma diagnosis: A population-based studyJournal of the American Academy of Dermatology, 2010
- Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality StudyCancer Causes & Control, 2008
- Risk of prostate, breast and colorectal cancer after skin cancer diagnosisInternational Journal of Cancer, 2008
- Are Patients with Skin Cancer at Lower Risk of Developing Colorectal or Breast Cancer?American Journal of Epidemiology, 2008
- Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor StudyBlood, 2008
- Increased risk of cancer in patients with fumarate hydratase germline mutationJournal of Medical Genetics, 2006
- Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972–2001European Journal of Cancer, 2005
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003
- Increased Risk of Second Primary Malignancies in Patients with Gynecological Cancer: A Swedish record-linkage studyActa Oncologica, 1995